These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32793473)

  • 1. Identification and Validation of Stage-Associated PBMC Biomarkers in Breast Cancer Using MS-Based Proteomics.
    Moradpoor R; Gharebaghian A; Shahi F; Mousavi A; Salari S; Akbari ME; Ajdari S; Salimi M
    Front Oncol; 2020; 10():1101. PubMed ID: 32793473
    [No Abstract]   [Full Text] [Related]  

  • 2. Two Distinct Subtypes Revealed in Blood Transcriptome of Breast Cancer Patients With an Unsupervised Analysis.
    Ming W; Xie H; Hu Z; Chen Y; Zhu Y; Bai Y; Liu H; Sun X; Liu Y; Gu W
    Front Oncol; 2019; 9():985. PubMed ID: 31632916
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of
    Moradpoor R; Zali H; Gharebaghian A; Akbari ME; Ajdari S; Salimi M
    Cell J; 2021 Sep; 23(4):406-413. PubMed ID: 34455715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer.
    Li H; Mao Y; Xiong Y; Zhao HH; Shen F; Gao X; Yang P; Liu X; Fu D
    Cancer Genomics Proteomics; 2019; 16(1):81-89. PubMed ID: 30587502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
    Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
    BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reference library of peripheral blood mononuclear cells for SWATH-MS analysis.
    Silva C; Santa C; Anjo SI; Manadas B
    Proteomics Clin Appl; 2016 Jul; 10(7):760-4. PubMed ID: 27188786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
    Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
    J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering transcriptome profiles of peripheral blood mononuclear cells in response to PRRSV vaccination in pigs.
    Islam MA; Große-Brinkhaus C; Pröll MJ; Uddin MJ; Rony SA; Tesfaye D; Tholen E; Hölker M; Schellander K; Neuhoff C
    BMC Genomics; 2016 Aug; 17(1):641. PubMed ID: 27528396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients.
    Suzuki E; Sugimoto M; Kawaguchi K; Pu F; Uozumi R; Yamaguchi A; Nishie M; Tsuda M; Kotake T; Morita S; Toi M
    Breast Cancer; 2019 May; 26(3):282-289. PubMed ID: 30317464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression and phosphorylation of the two S100A9 isoforms in mononuclear cells from patients with systemic lupus erythematosus: a proteomic signature for circulating low-density granulocytes.
    Pavón EJ; García-Rodríguez S; Zumaquero E; Perandrés-López R; Rosal-Vela A; Lario A; Longobardo V; Carrascal M; Abián J; Callejas-Rubio JL; Ortego-Centeno N; Zubiaur M; Sancho J
    J Proteomics; 2012 Mar; 75(6):1778-91. PubMed ID: 22230807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach.
    Obry A; Lequerré T; Hardouin J; Boyer O; Fardellone P; Philippe P; Le Loët X; Cosette P; Vittecoq O
    PLoS One; 2014; 9(12):e115800. PubMed ID: 25546405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for Microscale Extraction and Proteome Profiling of Peripheral Blood Mononuclear Cells.
    Yang L; Weng S; Qian X; Wang M; Ying W
    Anal Chem; 2022 Jun; 94(25):8827-8832. PubMed ID: 35699231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
    Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.
    Elghonaimy EA; Ibrahim SA; Youns A; Hussein Z; Nouh MA; El-Mamlouk T; El-Shinawi M; Mostafa Mohamed M
    Tumour Biol; 2016 Sep; 37(9):12441-12453. PubMed ID: 27329104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into significant pathways and gene interaction networks in peripheral blood mononuclear cells for early diagnosis of hepatocellular carcinoma.
    Jiang JX; Yu C; Li ZP; Xiao J; Zhang H; Chen MY; Sun CY
    J Cancer Res Ther; 2016; 12(2):981-9. PubMed ID: 27461685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
    Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
    Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement.
    Bonin S; Pracella D; Barbazza R; Dotti I; Boffo S; Stanta G
    Dis Markers; 2019; 2019():7832376. PubMed ID: 31781306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.